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Background: This study was aimed at determining the outcome and examining the association between
comorbidities and mortality after intracerebral hemorrhage in chronic dialysis patients.
Methods: We used the Taiwan National Health Insurance Research Database and enrolled patients who underwent
maintenance dialysis between 2000 and 2007. Annual incidence of intracerebral hemorrhage in patients receiving
dialysis from 2000 to 2007 was determined. To identify predictors of hemorrhagic stroke, we used logistic
regression model to estimate the relative ratio of factors for intracerebral hemorrhage in the most recent cohort
(2007). The cumulative survival rate and comorbid conditions associated with mortality after intracerebral
hemorrhage among all dialysis patients between 2000 and 2007 was calculated using the Kaplan-Meier method
and Cox regression analysis.
Results: We identified 57,261 patients on maintenance dialysis in the cohort of 2007, and 340 patients had history
of intracerebral hemorrhage among them. Hypertension was the most common comorbidity of dialysis patients.
The incidence rate of intracerebral hemorrhage among dialysis patients was about 0.6%. Adjusted logistic
regression model showed that male gender, middle age (45–64 years), hypertension, and previous history of stroke
were the independent predictors for the occurrence of intracerebral hemorrhage among chronic dialysis patients.
1,939 dialysis patients with development of intracerebral hemorrhage in the analysis period from 2000 to 2007 were
identified. In-hospital mortality was high (36.15%) following intracerebral hemorrhage. They were followed up after
intracerebral hemorrhage for a mean time of 41.56 months. Adjusted Cox regression analyses demonstrated that
the factors independently associated with mortality after intracerebral hemorrhage among dialysis patients included
diabetes mellitus, malignancy and a history of prior stroke.
Conclusions: Dialysis patients who have history of prior stroke, diabetes and malignancy have worse survival than
patients without these comorbidities. Attention must focus on providing optimal medical care after hemorrhagic
stroke for these target groups to reduce mortality.
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Cerebrovascular disease is a common cause of morbidity
and mortality in patients with end-stage renal disease
(ESRD). Patients with ESRD have advanced atheroscler-
osis of the cerebral vasculature [1]. Stroke rates for
ESRD patients are markedly higher than for the general
population [2]. Intracerebral hemorrhage (ICH) is a type
of stroke that involves bleeding within the brain tissue
itself. It is well known that a bleeding tendency is a
major concern among ESRD patients. In addition, the
routine administration of heparin during hemodialysis
may increase the risk of bleeding. ICH is more common
in dialysis patients than in the general population [2],
and is a devastating and life-threatening condition that
requires urgent intervention. The onset of ICH is usually
sudden and, unlike ischemic stroke symptoms, ICH
symptoms tend to appear without warning. ICH in dialy-
sis patients has a poor prognosis and a very high mortal-
ity rate, despite advances in diagnosis and treatment
[3,4]. It is important to identify dialysis patients at risk
for developing ICH and the prognostic factors after ICH.
ICH is more common among Taiwanese than Cauca-
sians [5]. The incidence and prevalence rates of ESRD
are also high in Taiwan [6]. However, little is known
about the annual incidence of ICH in the Taiwanese dia-
lysis population. There are also few nationwide studies
analyzing the predictors of ICH and the effect of co-
morbidities on survival following ICH in patients on
chronic dialysis. In the study, we utilized a large data set
from the National Health Insurance Research Database
(NHIRD) to identify predicting factors for intracerebral
hemorrhage in dialysis patients as the primary objective.
The secondary objective was to report the clinical out-
comes and identify the independent predictors of ICH
mortality in these patients.
Methods
Data source
Data for this cohort study was obtained from the
NHIRD (http://nhird.nhri.org.tw), which was released
for research purposes by the Taiwan National Health
Research Institute. The NHIRD, which includes nearly all
(99%) of the inpatient and outpatient medical benefit
claims for the Taiwanese population of 23 million people,
is one of the largest and most comprehensive databases
in the world and has been used extensively in various
studies [7]. The dataset was released with de-identified
secondary data for public research purposes. All types of
personal identification on files connected with the
present study were scrambled using surrogate identifica-
tion numbers to secure patient privacy. The study was
exempt for the need of written informed patient consent
by the Institutional Review Board of Chi-Mei medical
center (1008–002) and the Bureau of National HealthInsurance (NHRI-NHIRD-99182). We used the NHIRD
to collect the ambulatory care claims, all inpatient claims,
and the updated registry for beneficiaries from 2000 to
2007 for this study. All datasets can be interlinked
through each individual’s unique personal identification
number.
Patient selection and definition
We enrolled ESRD patients in the NHIRD who under-
went maintenance dialysis from January 1, 2000 to
December 31, 2007. Patients with ESRD are eligible for
any type of renal replacement therapy free of charge and
without co-payments in Taiwan. Patients on mainten-
ance dialysis were defined as having undergone dialysis
longer than 90 days. Patients who had undergone renal
transplantation before the initiation of dialysis were
excluded. We linked study subjects to the inpatient
claims data to identify newly diagnosed ICH (ICD-9-CM
code 431).
Ascertaining the demographic data and comorbidities
Data on age, gender, initial modality, and baseline co-
morbidities were recorded for each dialysis patient. The
baseline comorbidities included diabetes mellitus, hyper-
tension, heart failure, coronary artery disease, old stroke,
peripheral arterial disease, chronic lung disease, chronic
liver disease, and cancer. Selected comorbidities were
ascertained based on 1 in-patient claim or 3 out-patient
claims at the start of dialysis or during the follow-up.
The ICD-9-CM codes used to define clinical conditions
are shown in Additional file 1.
Statistical analyses
We assessed the annual incidence of ICH among dialysis
patients from 2000 to 2007. For each annual cohort, we
tabulated all characteristics by presence versus absence
of previous ICH, with continuous variables using means
and standard deviation and categorical variables using
counts and percentages. Because our selected subjects
were prevalent dialysis patients, which were not known
the time of initiation of dialysis, we used the most recent
cohort, for the year 2007, to identify the predictors of
ICH and used logistic regression models to estimate the
relative ratio for each factor. The cumulative survival
rate after developing ICH was calculated using the
Kaplan-Meier method. Hazard ratios for each factor
were calculated using Cox regression analysis to deter-
mine significant predictors for mortality among all dialy-
sis patients with occurrence of ICH between 2000 and
2007. If not addressed, p-values less than 0.05 were con-
sidered statistically significant. Data analysis was per-
formed using SPSS for Windows, version 17.0 (SPSS
Inc., Illinois, USA).
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Baseline demographic and clinical data
The patients on maintenance dialysis suffering from
ICH accounted for less than 1% of the total dialysis co-
hort. The majority of patients used hemodialysis as their
first modality of renal replacement therapy, but the rate
of utilization of peritoneal dialysis as primary treatment
for ESRD increased in the analysis period. The preva-
lence of comorbid conditions in the ESRD population
without ICH was substantial: hypertension was the most
common, followed by diabetes mellitus, chronic liver
disease, coronary artery disease, congestive heart failure,
prior stroke, chronic lung disease, cancer, and peripheral
artery disease, based on the year 2007 cohort. The fre-
quency of comorbidities among dialysis patients with
ICH was somewhat different from those without ICH;
i.e., prior stroke was the third most common disease.
Moreover, the prevalence of diabetes, hypertension and
previous history of stroke among dialysis patients suffer-
ing from ICH was even greater. The percentage of pa-
tients suffering from ICH in the peritoneal dialysis
group was less than in the hemodialysis group (Table 1).
Incidence rate and predictors of ICH in dialysis patients
The incidence rate of ICH in the dialysis population was
about 0.6%. 57,261 patients on maintenance dialysis were
identified in the most recent and largest cohort of 2007.
Results of adjusted logistic regression analysis showedTable 1 Characteristics of patients on maintenance dialysis in
versus absence of ICH
Characteristics 2000
No ICH n = 34282 ICH n = 230 No
No. (%
Age (mean ± SD), y 57.3 ± 14.5 58.9 ± 12
Female 18303 (53.4) 107 (46.5) 2
Dialysis modality
Hemodialysis 32340 (94.3) 224 (97.4) 4
Peritoneal dialysis 1942 (5.7) 6 (2.6)
ICH in-hospital days 11.2 (±15.9)
Comorbid conditions
Hypertension 17192 (50.1) 143 (62.2) 2
Diabetes 11356 (33.1) 101 (43.9) 1
Chronic liver disease 7528 (21.9) 26 (11.3) 1
Coronary artery disease 6252 (18.3) 48 (20.9)
Heart failure 3795 (11.1) 33 (14.3)
Prior stroke 3153 (9.3) 44 (19.1)
Chronic lung disease 3021 (8.8) 19 (8.3)
Peripheral artery disease 1858 (5.4) 11 (4.8)
Cancer 1116 (3.2) 2 (0.9)
ICH, Intracerebral hemorrhage.that male gender, middle age (45–64 years at baseline),
hypertension, and previous history of stroke were the in-
dependent predictors for ICH among chronic dialysis pa-
tients. ESRD patients on hemodialysis tended to have a
higher incidence of ICH than those on peritoneal dialysis;
however, there was no statistical significance (Table 2).
Predictors for all-cause mortality after ICH in dialysis
patients
1,939 dialysis patients with the occurrence of intracere-
bral hemorrhage from 2000 to 2007 were identified. The
mean of follow-up time after ICH was 41.56 months.
Overall, we found a high in-hospital mortality rate
(36.15%) among dialysis patients hospitalized with ICH.
In the univariate analysis of baseline data, diabetes melli-
tus, hypertension, coronary artery disease, previous his-
tory of stroke, chronic liver disease, and malignancy
were associated with higher mortality following ICH
hospitalization. The multivariate Cox regression analysis
showed that previous history of stroke, diabetes mellitus
and malignancy were independent predictors of mortal-
ity after ICH among dialysis patients. The in-hospital
mortality rate in patients with a prior history of stroke
was almost the same as in patients without a prior his-
tory of stoke (36.14% vs. 36.16%). Crude overall survival
curves after intracerebral hemorrhage among dialysis pa-
tients with and without prior stroke were shown in the
Figure 1. The two survival curves started to separate atselected years between 2000 and 2007 by presence
2004 2007
ICH n = 47555 ICH n = 289 No ICH n = 56921 ICH n = 340
)
59.1 ± 14.1 58.6 ± 12.5 60.7 ± 13.9 60.7 ± 11.9
5598 (53.8) 120 (41.5) 30186 (53.0) 155 (45.6)
4408 (93.4) 279 (96.5) 52569 (92.4) 320 (94.1)
2147 (6.6) 10 (3.5) 4352 (7.6) 20 (5.9)
10.9 (±11.3) 13.2 (±15.2)
5044 (52.7) 170 (58.8) 33072 (58.1) 238 (70.0)
5897 (33.4) 118 (40.8) 21559 (37.9) 166 (48.8)
1902 (25.0) 59 (20.4) 14203 (24.9) 91 (26.8)
9290 (19.6) 67 (23.2) 12355 (21.7) 88 (25.9)
5734 (12.1) 34 (11.8) 7300 (12.8) 46 (13.5)
4633 (9.8) 63 (21.8) 5815 (10.3) 91 (26.8)
3878 (8.2) 24 (8.3) 4209 (7.4) 21 (6.2)
1621 (3.4) 9 (3.1) 2803 (4.9) 27 (8.7)
2752 (5.8) 13 (4.5) 4150 (7.3) 21 (6.2)
Table 2 Logistic regression model to evaluate for
predictors of incidence of intracerebral hemorrhage in
patients on maintenance dialysis
Factors Univariate Multivariate
RR (95% CI) RR (95% CI)
Sex (Male v Female) 1.35 (1.09-1.67)* 1.25 (1.01-1.55)*
Age
<44 (Referent) 1 1
45-64 1.86 (1.25-2.77)* 1.56 (1.04-2.34)*
≥ 65 1.44 (0.96-2.17) 1.09 (0.71-1.67)
Dialysis modality (PD v HD) 0.76 (0.48-1.19) 0.81(0.51-1.29)
Comorbidities
Diabetic mellitus 1.57 (1.26-1.94)* 1.15 (0.91-1.46)
Hypertension 1.68 (1.33-2.12)* 1.37 (1.06-1.77)*
Heart failure 1.06 (0.78-1.45) 0.90 (0.65-1.24)
Coronary artery disease 1.26 (0.99-1.61) 1.04 (0.80-1.35)
Prior stroke 3.21 (2.52-4.09)* 2.86 (2.22-3.69)*
Peripheral arterial disease 1.67 (1.12-2.47)* 1.41 (0.94-2.10)
Chronic lung disease 0.82 (0.53-1.28) 0.74 (0.47-1.16)
Chronic liver disease 1.10 (0.86-1.40) 1.03 (0.81-1.31)
Cancer 0.84 (0.54-1.30) 0.90 (0.57-1.40)
*significant difference.
PD, Peritoneal dialysis; HD, Hemodialysis; CI, Confidence interval; RR, Relative ratio.
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1 year and 2 years after ICH differed between dialysis
patients with and without a history of prior stroke
(45.7% vs. 49.4%, 35.5% vs. 44.1% respectively) (log rank:
P = 0.02) (Figure 1) (Table 3).Figure 1 Crude overall survival curves after intracerebral hemorrhage
prior stroke.Discussion
This nationwide study was designed to investigate the
risk factors of ICH occurrence and predictors of mortal-
ity following ICH in prevalent dialysis patients using the
Taiwan National Health Insurance (NHI) database. We
found a high incidence rate of ICH among chronic dialy-
sis patients. Male gender, middle age, hypertension, and
history of old stroke were independent factors of inci-
dent ICH. Diabetes mellitus and malignancy were sig-
nificant independent predictors of mortality after ICH.
Long-term outcome of ICH survivors was much poorer
among the group with a history of prior stroke than
among those without a history of prior stroke.
The present findings confirm the high rate of ICH
among dialysis patients compared with the general
population reported in a prior study [2]. We also showed
that hypertension and male gender were independent
predictors of hemorrhagic stroke among patients on
chronic dialysis. These observations were consistent with
recent study by Yoo et al., who evaluated predictive vari-
ables of ICH in dialysis patients using the United States
Renal Data System (USRDS) database [8]. Similar results
were also observed in previous study by Seliger’s [9], in
which increased ICH rate was associated with a raised
mean arterial pressure of at least >10 mmHg. Thus,
hypertension is a risk factor for ICH for both the general
population and dialysis patients [10]. While higher blood
pressure has relevance to incidental ICH, the effect of it
on all-cause mortality seems to be different. We did not
find an association between hypertension and all-cause
mortality after ICH in patients undergoing chronicamong dialysis patients stratified as being with and without
Table 3 Cox regression model to evaluate for predictors






HR (95% CI) HR (95% CI)
Sex (male v female) 1.07 (0.96-1.20) 1.08 (0.96-1.20)
Age
<45 1 1
45-64 1.05 (0.86-1.27) 1.01 (0.82-1.23)
≥ 65 1.20 (0.98-1.47) 1.13 (0.91-1.39)




1.15 (1.03-1.29)* 1.14 (1.01-1.28)*
Hypertension (yes v no) 1.06 (0.94-1.18) 0.95 (0.83-1.08)
Heart failure (yes v no) 0.97 (0.82-1.15) 0.93 (0.78-1.11)
Coronary artery disease
(yes v no)
1.15 (1.01-1.31)* 1.09 (0.95-1.26)
Prior stroke (yes v no) 1.20 (1.05-1.36)* 1.17 (1.03-1.34)*
Peripheral arterial disease
(yes v no)
1.11 (0.87-1.43) 1.05 (0.82-1.35)
Chronic lung disease
(yes v no)
1.07 (0.87-1.32) 1.01 (0.82-1.26)
Chronic liver disease
(yes v no)
1.17 (1.02-1.33)* 1.12 (0.98-1.28)
Cancer (yes v no) 1.79 (1.39-2.31)* 1.74 (1.34-2.25)*
*significant difference.
PD, Peritoneal dialysis; HD, Hemodialysis; HR, Hazard ratio; CI, Confidence interval.
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an independent predictor of death among chronic dialy-
sis patients is in agreement with the work of Tetri and
colleagues, who investigated the factors associated with
outcome after ICH in the general population [11]. How-
ever, the observation of a null association between ele-
vated blood pressure and poor outcome of dialysis
patients should be interpreted with some caution. We
did not differentiate patients using antihypertensive
medications from those without treatment in this ana-
lysis, and it seems probable that the effect of hyperten-
sion is confounded by the use of these drugs.
This study found that previously diagnosed diabetes
predicted mortality. Diabetes was also demonstrated to
be an independent determinant of death in the general
population suffering from ICH [12]. The exact reason
why diabetes is associated with the risk of mortality fol-
lowing ICH remains unclear. The effect of DM on sur-
vival may be explained by the severity of hemorrhagic
events. Diabetes induces structural and functional
changes in the microvasculature that lead to fibrinoid
necrosis of blood vessel walls and microaneurysm for-
mation. It is possible that these changes in vessel wallsmake diabetic patients more likely to develop larger
sized hematomas than non-diabetics. There is evidence
showing that patients with an elevated glucose level due
to diabetes were associated with hemorrhages of a larger
size compared to patients with a normal glucose level
[13], and that the volume of ICH was a strong predictor
of mortality after primary ICH [14,15]. In addition, pa-
tients with uncontrolled diabetes and a high glucose
level may also have a higher risk of infectious or cardio-
vascular complications during hospitalization.
Moreover, we found that a previous medical history of
stroke is strongly associated with both a higher inci-
dence of ICH and higher mortality risk following ICH
among dialysis patients. The risk of ICH was reported to
increase several times after ischemic infarct in the gen-
eral population [16,17]. It is well established that dialysis
patients have a much higher incidence of cerebral is-
chemic events. Therefore, it is prudent to avoid over-
anticoagulation in these patients and to monitor them
more closely when providing antithrombotic drugs to
prevent recurrent ischemic infarction. A complex series
of pathophysiological events are initiated in the brain
after ischemic injury. It has been reported that matrix
metalloproteinases-2 (MMP-2), MMP-3 and MMP-9,
which are capable of digesting basal lamina and extracel-
lular matrix components and lead to subsequent blood
brain barrier breakdown and hemorrhagic transform-
ation, were abnormally upregulated in the ischemic re-
gion and peri-infarct area [18-20]. Increased expression
of MMP-9 of the brain tissue was also observed in pa-
tients suffering from hemorrhagic stroke [20]. Moreover,
the increased activities of inducible matrix proteases
may sustain for several months or years after brain in-
jury [21]. It is possible that physiologic and pathologic
responses to stroke cause chronic damage to vessel wall
components and pose a sustained risk of subsequent
ICH among dialysis patients.
The present study showed the in-hospital mortality
rate among dialysis patients hospitalized with ICH was
36.15%. This result correlated with previous reports
from other Asian countries. In a study from Korea, the
30-day mortality rate among 102 ESRD cases of spon-
taneous ICH was 53.9% [22]. Another study from Japan
using registered data showed that the death rate of dialy-
sis patients after cerebral hemorrhage was 27.9% [23]. A
recent study from Taiwan reported that the mortality
rate within 30 days after spontaneous ICH in the general
population was 19.8% [24]. Thus, the outcome of ICH is
poor among patients on chronic dialysis, and can be
worse than in the general population.
Whether gender has an impact on survival after stroke
remains controversial. It has been suggested that estro-
gen may exert neuroprotective effects after brain injury
by way of stimulating insulin-like growth factor-I
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free radicals, and stimulation of intrinsic anti-apoptotic
pathways [25,26]. A recent study demonstrated a signifi-
cant survival advantage for females over males over 3-
year period after primary ICH [27]. Another study in
Denmark also revealed a female superiority in survival
time after stroke [28]. However, we did not find such an
association between female gender and lower all-cause
mortality rates after hemorrhagic stroke among chronic
dialysis patients.
Peritoneal dialysis (PD) was claimed to have some ben-
efits, such as minimal anticoagulation and improved car-
diovascular or intracranial stability as a consequence of
smaller changes in serum osmolality. There is also evi-
dence showing that intracranial pressure increased sig-
nificantly in patients receiving conventional intermittent
hemodialysis [29]. So patients on PD were expected to
experience fewer acute cerebral events compared with
those on hemodialysis (HD), and some authors suggest a
survival advantage with the use of PD instead of HD for
chronic dialysis patients with cerebral hemorrhage
[30,31]. In the USRDS study by Yoo mentioned above,
use of peritoneal dialysis as long-term renal replacement
therapy was associated with lower risk of ICH compared
to use of hemodialysis [8]. However, there is a contra-
dictory result. A recent work showed an even worse
prognosis for patients receiving PD after ICH [4]. Our
analysis did not support the association of PD as a dialy-
sis modality with less incidental ICH or decreased mor-
tality following ICH among chronic dialysis patients.
The strength of our study lies in its large population
size, and high likelihood that nearly all relevant patients
were collected from the database. The limitations of this
study include a lack of laboratory data, and a lack of in-
formation about the causes of death, because they were
not included in the Taiwan NHI database. We used
ICD-9 code 431 to identify cases of ICH, so patients
with isolated subarachnoid hemorrhage (ICD-9 code:
430) would not be included in our analysis. We could
not affirmatively determine the duration and severity of
comorbidities, which may influence outcome of our sub-
jects, in the databases-derived study. We did not have
access to detailed information about ICH and dialysis, so
the severity and location of the ICH, blood pressure
values, and dialysis adequacy cannot be assessed. Surgery
was required in patients with large hematoma formation
or refractory elevated intracranial pressure. Operation
may have an influence on short-term mortality or long-
term disability in our study subjects but we did not
analyze the proportion of patients receiving surgical
treatment after ICH. Moreover, we did not evaluate drug
treatment in ESRD population, such as antiplatelet or
anticoagulants, which may be associated with incidence
of ICH. We also did not differentiate ischemic strokefrom hemorrhagic stroke in determining comorbidities.
Further large prospective studies with detailed evalua-
tions are needed to confirm our findings.
Conclusion
In summary, our nationwide study showed that patients
on chronic dialysis had a high risk of hemorrhagic
stroke. The factors associated with ICH occurrence and
post-hemorrhage survival of these patients were some-
what different from the traditionally reported risk factors
for ICH. Dialysis patients that have history of prior
stroke, diabetes or malignancy have worse survival than
patients without these comorbidities. It is important to
identify patients with modifiable risks; this will enable
clinicians to provide the patients with preventive strat-
egies and best medical care to achieve better outcomes
during the dialysis period.
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